STD Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments and Services, Consumables), By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2024 - 2030

Market Segmentation 

• STD Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Instruments and Services
  • Consumables
  • Software
• STD Diagnostics Application Outlook (Revenue, USD Million, 2018 - 2030)
  • CT/NG testing
  • Syphilis testing
  • PCR testing
  • Non-PCR testing
  • Gonorrhea testing
  • HSV testing
  • PCR testing
  • Non-PCR testing
  • HPV testing
  • HIV testing
  • Ureaplasma & Mycoplasma testing
  • Trichomonas
  • VZV testing
  • PCR testing
  • Non-PCR test
• STD Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Immunoassay
  • Molecular Diagnostics
  • Other
• STD Diagnostics Location of Testing Outlook (Revenue, USD Million, 2018 - 2030)
  • Commercial/Private labs
  • Public Health Labs
• STD Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America STD Diagnostics Market, by Product
      • Instruments and Services
      • Consumables
      • Software
    • North America STD Diagnostics Market, by Application
      • CT/NG testing
      • Syphilis testing
      • PCR testing
      • Non-PCR testing
      • Gonorrhea testing
      • HSV testing
      • PCR testing
      • Non-PCR testing
      • HPV testing
      • HIV testing
      • Ureaplasma & Mycoplasma testing
      • Trichomonas
      • VZV testing
      • PCR testing
      • Non-PCR test
    • North America STD Diagnostics Market, by Technology
      • Immunoassay
      • Molecular Diagnostics
      • Other
    • North America STD Diagnostics Market, by Location of Testing
      • Laboratory Testing
        • Commercial/Private labs
        • Public Health Labs
      • Point of Care Testing
    • U.S.
      • U.S. STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • U.S. STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • U.S. STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • U.S. STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Canada
      • Canada STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Canada STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Canada STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Canada STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
  • Europe
    • Europe STD Diagnostics Market, by Product
      • Instruments and Services
      • Consumables
      • Software
    • Europe STD Diagnostics Market, by Application
      • CT/NG testing
      • Syphilis testing
      • PCR testing
      • Non-PCR testing
      • Gonorrhea testing
      • HSV testing
      • PCR testing
      • Non-PCR testing
      • HPV testing
      • HIV testing
      • Ureaplasma & Mycoplasma testing
      • Trichomonas
      • VZV testing
      • PCR testing
      • Non-PCR test
    • Europe STD Diagnostics Market, by Technology
      • Immunoassay
      • Molecular Diagnostics
      • Other
    • Europe STD Diagnostics Market, by Location of Testing
      • Laboratory Testing
        • Commercial/Private labs
        • Public Health Labs
      • Point of Care Testing
    • UK
      • UK STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • UK STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • UK STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • UK STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Germany
      • Germany STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Germany STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Germany STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Germany STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • France
      • France STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • France STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • France STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • France STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Italy
      • Italy STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Italy STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Italy STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Italy STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Spain
      • Spain STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Spain STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Spain STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Spain STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Denmark
      • Denmark STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Denmark STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Denmark STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Denmark STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Sweden
      • Sweden STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Sweden STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Sweden STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • SwedenSTD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Norway
      • Norway STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Norway STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Norway STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Norway STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
  • Asia Pacific
    • Asia Pacific STD Diagnostics Market, by Product
      • Instruments and Services
      • Consumables
      • Software
    • Asia Pacific STD Diagnostics Market, by Application
      • CT/NG testing
      • Syphilis testing
      • PCR testing
      • Non-PCR testing
      • Gonorrhea testing
      • HSV testing
      • PCR testing
      • Non-PCR testing
      • HPV testing
      • HIV testing
      • Ureaplasma & Mycoplasma testing
      • Trichomonas
      • VZV testing
      • PCR testing
      • Non-PCR test
    • Asia Pacific STD Diagnostics Market, by Technology
      • Immunoassay
      • Molecular Diagnostics
      • Other
    • Asia Pacific STD Diagnostics Market, by Location of Testing
      • Laboratory Testing
        • Commercial/Private labs
        • Public Health Labs
      • Point of Care Testing
    • India
      • India STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • India STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • India STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • India STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • China
      • China STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • China STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • China STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • v STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Japan
      • Japan STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Japan STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Japan STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Japan STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Australia
      • Australia STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Australia STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Australia STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Australia STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • South Korea
      • South Korea STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • South Korea STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • South Korea STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • South Korea STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Thailand
      • Thailand STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Thailand STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Thailand STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Thailand STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
  • Latin America
    • Latin America STD Diagnostics Market, by Product
      • Instruments and Services
      • Consumables
      • Software
    • Latin America STD Diagnostics Market, by Application
      • CT/NG testing
      • Syphilis testing
      • PCR testing
      • Non-PCR testing
      • Gonorrhea testing
      • HSV testing
      • PCR testing
      • Non-PCR testing
      • HPV testing
      • HIV testing
      • Ureaplasma & Mycoplasma testing
      • Trichomonas
      • VZV testing
      • PCR testing
      • Non-PCR test
    • Latin America STD Diagnostics Market, by Technology
      • Immunoassay
      • Molecular Diagnostics
      • Other
    • Latin America STD Diagnostics Market, by Location of Testing
      • Laboratory Testing
        • Commercial/Private labs
        • Public Health Labs
      • Point of Care Testing
    • Argentina
      • Argentina STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Argentina STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Argentina STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Argentina STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Brazil
      • Brazil STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Brazil STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Brazil STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Brazil STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Mexico
      • Mexico STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Mexico STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Mexico STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Mexico STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
  • Middle East & Africa
    • Middle East & Africa STD Diagnostics Market, by Product
      • Instruments and Services
      • Consumables
      • Software
    • Middle East & Africa  STD Diagnostics Market, by Application
      • CT/NG testing
      • Syphilis testing
      • PCR testing
      • Non-PCR testing
      • Gonorrhea testing
      • HSV testing
      • PCR testing
      • Non-PCR testing
      • HPV testing
      • HIV testing
      • Ureaplasma & Mycoplasma testing
      • Trichomonas
      • VZV testing
      • PCR testing
      • Non-PCR test
    • Middle East & Africa STD Diagnostics Market, by Technology
      • Immunoassay
      • Molecular Diagnostics
      • Other
    • Middle East & Africa STD Diagnostics Market, by Location of Testing
      • Laboratory Testing
        • Commercial/Private labs
        • Public Health Labs
      • Point of Care Testing
    • Saudi Arabia
      • Saudi Arabia STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Saudi Arabia STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Saudi Arabia STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Saudi Arabia STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • UAE
      • UAE STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • UAE STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • UAE  STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • UAE STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • South Africa
      • South Africa STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • South Africa STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • South Africa STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • South Africa STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing
    • Kuwait
      • Kuwait STD Diagnostics Market, by Product
        • Instruments and Services
        • Consumables
        • Software
      • Kuwait STD Diagnostics Market, by Application
        • CT/NG testing
        • Syphilis testing
        • PCR testing
        • Non-PCR testing
        • Gonorrhea testing
        • HSV testing
        • PCR testing
        • Non-PCR testing
        • HPV testing
        • HIV testing
        • Ureaplasma & Mycoplasma testing
        • Trichomonas
        • VZV testing
        • PCR testing
        • Non-PCR test
      • Kuwait STD Diagnostics Market, by Technology
        • Immunoassay
        • Molecular Diagnostics
        • Other
      • Kuwait STD Diagnostics Market, by Location of Testing
        • Laboratory Testing
          • Commercial/Private labs
          • Public Health Labs
        • Point of Care Testing

STD Diagnostics Market Market Dynamics

Driver: Growing Global Disease Burden Of Std

The in vitro diagnostics market is expected to experience significant growth due to the increasing incidence of sexually transmitted infections (STIs) such as syphilis, gonorrhea, chlamydia, HIV, and HPV. According to the World Health Organization (WHO), there are approximately 376 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis recorded annually. Additionally, over 500 million people are estimated to have genital herpes simplex virus (HSV), and around 300 million women have human papillomavirus (HPV) infection, which is the leading cause of cervical cancer. The total number of new cases of HIV was found to be 1.5 million in 2020. The increasing prevalence of these STIs is expected to provide the in vitro diagnostics market with a large target population. The market is also expected to benefit from the growing demand for rapid and on-site testing solutions, as well as continuous advancements in diagnostic technologies, such as molecular diagnostics, immunoassays, and point-of-care testing. 

Driver: Technological Advancements In Std Diagnostics

Technological advancements related to accuracy, portability, and cost-effectiveness are expected to drive the market over the forecast period. Key players are expanding their test portfolios, which include qPCR instruments, by investing in R&D to develop diagnostic kits that can identify emerging diseases or by entering into agreements with other kit manufacturing companies. In April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. for USD 24.05 per share in cash and holds around 82.89% of the total shares of the company. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, that can be utilized in developing infectious disease tests, including bloodstream infections. Furthermore, the development and commercialization of advanced products, such as multiplex PCR products and next-generation HIV testing kits, enable physicians to timely distinguish and diagnose a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, the Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In July 2021, Danaher (Cepheid) received CE marking for its next-generation extended coverage tests for HIV testing in patients, which include Xpert HIV-1 Viral Load XC and Xpert HIV-1 Qual XC. The availability of an at-home collection and self-testing kits reduces patient visits to clinics and promotes patint discretion as well.

Restraint: Vaccination Coverage For Std

The increasing number of government initiatives aimed at containing the STD epidemic, including regular screening guidelines and vaccination coverage for various diseases, is expected to have a significant impact on the in vitro diagnostics market. These initiatives are designed to reduce the overall disease burden in the region, which may have an adverse effect on market growth. For example, the vaccination coverage for diseases such as HPV and herpes zoster virus has been increasing, which is expected to contribute to the reduction of disease prevalence. However, the availability of at-home collection and self-testing kits is also reducing patient visits to clinics and promoting discretion among patients, which may offset the potential impact of government initiatives on market growth. 

What Does This Report Include?

This section will provide insights into the contents included in this STD diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

STD diagnostics market qualitative analysis

• Industry overview

• Industry trends

• Market drivers and restraints

• Market size

• Growth prospects

• Porter’s analysis

• PESTEL analysis

• Key market opportunities prioritized

• Competitive landscape

  • Company overview

  • Financial performance

  • Product benchmarking

  • Latest strategic developments

STD diagnostics market quantitative analysis

• Market size, estimates, and forecast from 2018 to 2030

• Market estimates and forecast for product segments up to 2030

• Regional market size and forecast for product segments up to 2030

• Market estimates and forecast for application segments up to 2030

• Regional market size and forecast for application segments up to 2030

• Company financial performance